Clinical Scorecard: Understanding Sarcopenia in Heart Failure: Perspectives from the Global Leadership Initiative on Sarcopenia Framework

At a Glance

Key Highlights

• Sarcopenia is a muscle-centred condition characterized by decreased muscle mass, strength, and function, exacerbated by heart failure.
• The Global Leadership Initiative on Sarcopenia (GLIS) framework includes muscle mass, muscle strength, and muscle-specific strength, distinguishing it from other definitions by treating physical performance as an outcome rather than a diagnostic criterion.
• GLIS-defined sarcopenia in heart failure patients is independently associated with higher 2-year mortality and improves prognostic risk classification compared to existing criteria.

Guideline-Based Recommendations

Diagnosis

• Use the GLIS framework incorporating muscle mass, muscle strength, and muscle-specific strength for sarcopenia diagnosis in heart failure patients.
• Consider physical performance measures as outcome indicators rather than diagnostic requirements due to confounding factors in heart failure.
• Recognize possible sarcopenia for early identification of functional limitations.

Management

• Target early interventions such as structured exercise training, nutritional optimization, and cardiac rehabilitation for patients with sarcopenia or possible sarcopenia.
• Personalize care pathways and follow-up intensity based on sarcopenia status.

Monitoring & Follow-up

• Assess muscle mass and strength during hospitalization and physical performance in clinically stable phases.
• Consider incorporating lower limb strength assessments alongside handgrip strength for comprehensive evaluation.

Risks

• Be aware of potential confounding factors affecting physical performance measures in heart failure.
• Recognize limitations of bioelectrical impedance analysis in volume-overloaded states common in heart failure.
• Understand that handgrip strength may not fully capture lower limb muscle deficits relevant to exercise intolerance.

Patient & Prescribing Data

Older Japanese patients hospitalized with heart failure

GLIS-defined sarcopenia identifies a broader spectrum of muscular impairment and is linked to worse prognosis, supporting early and targeted interventions.

Clinical Best Practices

• Adopt the GLIS framework for more accurate and prognostically relevant sarcopenia diagnosis in heart failure patients.
• Incorporate muscle-specific strength measurements to better characterize muscle quality.
• Use sarcopenia status to guide personalized management plans including rehabilitation and nutritional support.
• Validate and standardize muscle mass and strength assessment methods specifically for heart failure populations.
• Consider ethnic and demographic variability when applying sarcopenia diagnostic criteria.

References

• Prognostic utility of the Global Leadership Initiative on Sarcopenia model in older patients with heart failure: post-hoc analysis of the FRAGILE-HF study